New GLP-1 Receptor Agonists (Diabetes & Weight) treatments in trials

Semaglutide, Tirzepatide, Liraglutide — diabetes & weight management therapies. Track the treatments still in clinical testing and see which are closest to an FDA decision.

115Closest to approval (Phase 3)
161Mid-stage (Phase 2)
108Early stage (Phase 1)
1,943Total recruiting
In one line

1,943 glp-1 receptor agonists (diabetes & weight) trials are recruiting right now, 115 of them in Phase 3 — the stage immediately before an FDA decision.

Recruiting now

Twelve of the currently recruiting studies. Open one for a plain-English summary of who it is for and what it involves.

NCT07675551NARecruitingPeel Family Diabetes Prevention ProgramSponsorTrillium Health PartnersEnrolling280Summary NCT07505745Phase 2RecruitingMOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/ObesitySponsorHudson BiotechEnrolling120Summary NCT06735599NARecruitingWild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood PressureSponsorGeorgia State UniversityEnrolling40Summary NCT05074732RecruitingDundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.SponsorHealth Service Executive, IrelandEnrolling350Summary NCT05009433NARecruitingHIIT vs MICT During Pregnancy and Health and Birth Outcomes in Mothers and ChildrenSponsorGdansk University of Physical Education and SportEnrolling600Summary NCT06338215NARecruitingAdvice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and MortalitySponsorClinica Universidad de Navarra, Universidad de NavarraEnrolling10,000Summary NCT05958706RecruitingMitochondrial Substrate Utilization in the Diabetic Human HeartSponsorHeinrich-Heine University, DuesseldorfEnrolling500Summary NCT07778524Phase 1RecruitingAlpelisib Challenge Test (ACT)SponsorColumbia UniversityEnrolling15Summary NCT05007990RecruitingCaregiving Networks Across Disease Context and the Life CourseSponsorNational Human Genome Research Institute (NHGRI)Enrolling2,800Summary NCT05951660NARecruitingSex, Psychopharmacology, and DiabetesSponsorZealand University HospitalEnrolling256Summary NCT05759676RecruitingEfficacy and Safety of Polymer-free Amphilimus-eluting Stent According to the DiabetesSponsorKorea University Anam HospitalEnrolling1,800Summary NCT07106879RecruitingNon-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.SponsorClindove Research LLCEnrolling7,000Summary

View all 1,943 on ClinicalTrials.gov

Already approved for this area

GLP-1 Receptor Agonists

Ozempic, Mounjaro, Wegovy, Zepbound — approved products with their NDC records and billing codes.

Open the class

Every NDC in this class

The FDA registry filtered to glp-1 receptor agonists, with packaging and 11-digit billing conversions.

Search the directory

Loading the trial explorer…